Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Non-Infectious Macular Edema Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market ...

Vabysmo is a bispecific antibody designed to inhibit vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2).

The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...

Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...

A recent study published in the journal Nature Medicine showed that targeting senescent cells in the retina can be a lasting disease-modifying treatment for diabetic macular edema (DME). The retina is ...

Diabetic macular edema (DME) is a diabetes complication that can cause vision loss or blindness. It happens when high blood sugar damages the eye’s blood vessels, causing fluid buildup in the macula.

Select your location to view local American Lung Association events and news near you.

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — Optical coherence tomography is a valuable tool in supporting treatment of macular edema, but ...

The eye is made up of several different parts. One of these parts is the retina, which is home to special nerve cells that respond to light. The macula is part of that network and is located in the ...

LONDON--(BUSINESS WIRE)--The global diabetic macular edema treatment market 2018-2022 is expected to post a CAGR of more than 1% during the forecast period, according to the latest market research ...